To put what is being discussed at the EU Summit on Chronic Diseases this week into context, I thought it might be helpful to pass on some
great facts and figures that I’ve received from the International Diabetes Federation
on diabetes and its prevalence in Europe. I think it’s really important for us
to look at diabetes on a wider scale, as it can often help us put our own
conditions and management into context. Or provide us with inspiration for new
ways of approaching diabetes care.
- There are 56.3 million people with diabetes
living in Europe (8.5 % of the population)
- 21.2 million people are yet to be
diagnosed, so raising awareness and education on prevention is really important
- One in ten deaths can be attributed to
diabetes (622,114 deaths in 2012!). A statistic that is just too high and that we
need to act on now
- €138.8 billion were spent on treating
diabetes in Europe in 2012, a staggering amount.
- Europe is home to the highest number of
children with type 1 diabetes in the world, which makes education and
prevention high on the agenda for diabetes management so as to prevent
complications in adulthood
- >50% of adults with diabetes fail to
achieve target HbA1c values, which will put them at risk of possible diabetes
related complications in later life.
MSD- one of the pharmaceutical companies in attendance at the EU Summit on
Chronic Illnesses event has spent USD 27.8 billion on research and development
in the past 3 years alone and is the third largest spender on research and
development in the world. Tomorrow I look forward to spending time on their
stand and interacting with delegates who want to know more about what it’s like
to live with diabetes.
0 comments:
Post a Comment